Latest Capital Raises News

Kula Gold has raised $750,000 through a share placement to fund diamond drilling at its Mt Palmer Gold Mine, following a series of promising high-grade gold results from recent exploration.

AdNeo Limited has won overwhelming shareholder approval to acquire Learnt Global Group and is raising $5.5 million through a strategic placement, setting the stage for accelerated growth.

Tuas Limited has raised A$385 million through an institutional placement at $5.51 per share to fund its acquisition of M1, while also initiating a share purchase plan to raise an additional A$50 million from existing shareholders.

Macarthur Minerals has provided updated details ahead of its 2025 AGM regarding share issuances and convertible note conversions that affect key shareholder voting power. The changes notably adjust the stakes of Gold Valley Yilgarn Pty Ltd and Copulos Group.

Sayona Mining’s merger with Piedmont Lithium faces further delay due to shareholder quorum shortfall, prompting an extension of its financing agreement with Resource Capital Fund VIII. The extension includes a potential AU$38 million capital injection through new options.

Resouro Strategic Metals announces the immediate resignation of CEO Alistair Stephens, with Executive Chairman Christopher Eager stepping in as interim CEO. The company also plans to appoint a new Chairman to strengthen its leadership team.

Resouro Strategic Metals reports a significant update to its Tiros project resource alongside a reduced quarterly loss, highlighting progress in its Brazilian exploration assets.

Kelly Partners Group Holdings posted a robust 24.5% revenue increase to $134.6 million in FY25, driven by strategic international expansions and acquisitions. The firm’s underlying profit after tax also rose 13%, underscoring its growing footprint across Australia, the US, and Ireland.

Tesoro Gold has successfully dismissed initial legal claims from joint venture partner Wanaco SpA and increased its ownership in the El Zorro Gold Project to over 90%, reinforcing its strategic position in Chile.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Everest Metals Corporation has raised $4 million through a share placement to advance its gold and critical minerals projects in Western Australia, including pioneering rubidium extraction technology.

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.